{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T23:47:06Z","timestamp":1793490426726,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-03178-2","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:00:28Z","timestamp":1765432828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating therapeutic potential of Evodiamine by identifying differentially expressed genes in cisplatin resistance non-small cell lung cancer"],"prefix":"10.1007","volume":"43","author":[{"given":"Sambit Kumar","family":"Patra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambit Kumar","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahid Alim","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijesh Kumar","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"3178_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102177","author":"SK Patra","year":"2024","unstructured":"Patra SK, et al. Enigmatic exosomal connection in lung cancer drug resistance. Mol Ther Nucleic Acids. 2024. https:\/\/doi.org\/10.1016\/j.omtn.2024.102177.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3178_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e10608","author":"R Ranasinghe","year":"2022","unstructured":"Ranasinghe R, Mathai ML, Zulli A. Cisplatin for cancer therapy and overcoming chemoresistance. Heliyon. 2022:e10608. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10608.","journal-title":"Heliyon"},{"issue":"1","key":"3178_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12032-023-02237-w","volume":"41","author":"R Fu","year":"2023","unstructured":"Fu R, et al. Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy. Med Oncol. 2023;41(1):9.","journal-title":"Med Oncol"},{"issue":"1","key":"3178_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11033-023-09026-8","volume":"51","author":"MR Karimzadeh","year":"2024","unstructured":"Karimzadeh MR, et al. Co-treatment of silymarin and cisplatin inhibited cell proliferation, induced apoptosis in ovarian cancer. Mol Biol Rep. 2024;51(1):118.","journal-title":"Mol Biol Rep"},{"key":"3178_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2023.105697","volume":"151","author":"S Biswal","year":"2023","unstructured":"Biswal S, et al. Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer. Arch Oral Biol. 2023;151:105697.","journal-title":"Arch Oral Biol"},{"key":"3178_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2023.105687","volume":"93","author":"F Omidi","year":"2023","unstructured":"Omidi F, et al. Glycyrrhizic acid enhances the anticancer activity of cisplatin in the human ovarian cancer cell line. Toxicol In Vitro. 2023;93:105687.","journal-title":"Toxicol In Vitro"},{"issue":"9","key":"3178_CR7","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1007\/s11033-023-08664-2","volume":"50","author":"M Jalalpour Choupanan","year":"2023","unstructured":"Jalalpour Choupanan M, Shahbazi S, Reiisi S. Naringenin in combination with quercetin\/fisetin shows synergistic anti-proliferative and migration reduction effects in breast cancer cell lines. Mol Biol Rep. 2023;50(9):7489\u2013500.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3178_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/biomedicines12010183","volume":"12","author":"M Eslami","year":"2024","unstructured":"Eslami M, et al. Overcoming chemotherapy resistance in metastatic cancer: a comprehensive review. Biomedicines. 2024;12(1):183.","journal-title":"Biomedicines"},{"issue":"7","key":"3178_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.21037\/tlcr-22-444","volume":"11","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, et al. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Transl Lung Cancer Res. 2022;11(7):1479.","journal-title":"Transl Lung Cancer Res"},{"key":"3178_CR10","doi-asserted-by":"publisher","unstructured":"Shi L, et al. ntegrative bulk RNA analysis unveils immune evasion mechanisms and predictive biomarkers of osimertinib resistance in non-small cell lung cancer. Discov Oncol. 2025;16(1):1541. https:\/\/doi.org\/10.1007\/s12672-025-02529-9","DOI":"10.1007\/s12672-025-02529-9"},{"key":"3178_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113054","volume":"150","author":"S Hashem","year":"2022","unstructured":"Hashem S, et al. Targeting cancer signaling pathways by natural products: exploring promising anti-cancer agents. Biomed Pharmacother. 2022;150:113054.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3178_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s43042-025-00647-1","volume":"26","author":"A Shirani","year":"2025","unstructured":"Shirani A, et al. Pyrogallol acts as a novel anticancer factor to enhance the sensitivity to cisplatin in ovarian cancer cells through inducing miR-15a upregulation. Egypt J Med Hum Genet. 2025;26(1):15.","journal-title":"Egypt J Med Hum Genet"},{"issue":"1","key":"3178_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/cbin.11942","volume":"47","author":"SS Hosseini","year":"2023","unstructured":"Hosseini SS, et al. Study of quercetin and fisetin synergistic effect on breast cancer and potentially involved signaling pathways. Cell Biol Int. 2023;47(1):98\u2013109.","journal-title":"Cell Biol Int"},{"issue":"6","key":"3178_CR14","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1002\/biof.70050","volume":"51","author":"RK Sahoo","year":"2025","unstructured":"Sahoo RK, et al. Piperlongumine triggers reactive oxygen species driven mitochondrial dysfunction leading to apoptosis in human colon cancer cells. Biofactors. 2025;51(6):e70050.","journal-title":"Biofactors"},{"key":"3178_CR15","doi-asserted-by":"publisher","first-page":"685002","DOI":"10.3389\/fphar.2021.685002","volume":"12","author":"Q Sun","year":"2021","unstructured":"Sun Q, et al. Traditional Chinese medicine and colorectal cancer: implications for drug discovery. Front Pharmacol. 2021;12:685002.","journal-title":"Front Pharmacol"},{"issue":"1","key":"3178_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-022-09772-8","volume":"39","author":"M Panda","year":"2023","unstructured":"Panda M, et al. Evodiamine as an anticancer agent: a comprehensive review on its therapeutic application, pharmacokinetic, toxicity, and metabolism in various cancers. Cell Biol Toxicol. 2023;39(1):1\u201331.","journal-title":"Cell Biol Toxicol"},{"key":"3178_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174215","volume":"906","author":"T Wang","year":"2021","unstructured":"Wang T, et al. A novel evodiamine amino derivative as a PI3K\/AKT signaling pathway modulator that induces apoptosis in small cell lung cancer cells. Eur J Pharmacol. 2021;906:174215.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"3178_CR18","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","volume":"95","author":"J De Las Rivas","year":"2021","unstructured":"De Las Rivas J, et al. Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch Toxicol. 2021;95(7):2279\u201397.","journal-title":"Arch Toxicol"},{"issue":"1","key":"3178_CR19","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1038\/s41598-021-85930-y","volume":"11","author":"AN Hossian","year":"2021","unstructured":"Hossian AN, et al. Advanced bioinformatic analysis and pathway prediction of NSCLC cells upon cisplatin resistance. Sci Rep. 2021;11(1):6520.","journal-title":"Sci Rep"},{"key":"3178_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1011659","volume":"13","author":"L Yang","year":"2022","unstructured":"Yang L, et al. Identification of protein\u2013protein interaction associated functions based on gene ontology and KEGG pathway. Front Genet. 2022;13:1011659.","journal-title":"Front Genet"},{"issue":"4","key":"3178_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biology14040399","volume":"14","author":"Y Niu","year":"2025","unstructured":"Niu Y, et al. Three circulating miRNAs related to non-small-cell lung cancer progression: an integrative analysis of their biological roles. Biol. 2025;14(4):399.","journal-title":"Biol"},{"issue":"1","key":"3178_CR22","first-page":"29","volume":"2","author":"N Comfort","year":"2021","unstructured":"Comfort N, et al. Isolation and characterization of extracellular vesicles in saliva of children with asthma. Extracell Vesicles Circulating Nucleic Acids. 2021;2(1):29.","journal-title":"Extracell Vesicles Circulating Nucleic Acids"},{"key":"3178_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.855789","volume":"13","author":"Y Yao","year":"2022","unstructured":"Yao Y, Li Z, Gao W. Identification of hub genes in idiopathic pulmonary fibrosis and NSCLC progression: evidence from bioinformatics analysis. Front Genet. 2022;13:855789.","journal-title":"Front Genet"},{"key":"3178_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2020.105030","volume":"122","author":"P Arumugam","year":"2021","unstructured":"Arumugam P, George R, Jayaseelan VP. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma. Arch Oral Biol. 2021;122:105030.","journal-title":"Arch Oral Biol"},{"issue":"W1","key":"3178_CR25","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gkab418","volume":"49","author":"C Li","year":"2021","unstructured":"Li C, et al. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242\u20136.","journal-title":"Nucleic Acids Res"},{"key":"3178_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119105","volume":"270","author":"C Yuan","year":"2021","unstructured":"Yuan C, et al. Network pharmacology and molecular docking reveal the mechanism of Scopoletin against non-small cell lung cancer. Life Sci. 2021;270:119105.","journal-title":"Life Sci"},{"issue":"6","key":"3178_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/jfpp.15530","volume":"45","author":"F Al Juhaimi","year":"2021","unstructured":"Al Juhaimi F, et al. Effect of cold press and Soxhlet extraction systems on total carotenoid, antioxidant activity values and phytochemicals in caper (Capparis ovata var herbacea) seed oils. J Food Process Preserv. 2021;45(6):e15530.","journal-title":"J Food Process Preserv"},{"issue":"1","key":"3178_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11033-024-09477-7","volume":"51","author":"M Panda","year":"2024","unstructured":"Panda M, Biswal S, Biswal BK. Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-\u03b2-catenin axis. Mol Biol Rep. 2024;51(1):523.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3178_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30671","volume":"126","author":"S Biswal","year":"2025","unstructured":"Biswal S, Panda M, Biswal BK. Shikonin stimulates mitochondria-mediated apoptosis by enhancing intracellular reactive oxygen species production and DNA damage in oral cancer cells. J Cell Biochem. 2025;126(1):e30671.","journal-title":"J Cell Biochem"},{"issue":"8","key":"3178_CR30","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1007\/s00210-024-02965-4","volume":"397","author":"SK Tripathi","year":"2024","unstructured":"Tripathi SK, Sahoo RK, Biswal BK. Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(8):5631\u201347.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"9","key":"3178_CR31","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1002\/jcb.30304","volume":"123","author":"M Panda","year":"2022","unstructured":"Panda M, Biswal BK. Evodiamine inhibits stemness and metastasis by altering the SOX9\u2013\u03b2-catenin axis in non\u2010small\u2010cell lung cancer. J Cell Biochem. 2022;123(9):1454\u201366.","journal-title":"J Cell Biochem"},{"issue":"1","key":"3178_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-025-00647-2","volume":"14","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhang B. Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer. Exp Hematol Oncol. 2025;14(1):54.","journal-title":"Exp Hematol Oncol"},{"issue":"1","key":"3178_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01315-w","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang Y, et al. Targeting CD24 as a novel immunotherapy for solid cancers. Cell Commun Signal. 2023;21(1):312.","journal-title":"Cell Commun Signal"},{"key":"3178_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1008027","volume":"12","author":"X Duan","year":"2022","unstructured":"Duan X, et al. Overcoming therapeutic resistance to platinum-based drugs by targeting epithelial\u2013mesenchymal transition. Front Oncol. 2022;12:1008027.","journal-title":"Front Oncol"},{"key":"3178_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.762817","volume":"11","author":"SO Imodoye","year":"2021","unstructured":"Imodoye SO, et al. Understanding the complex milieu of epithelial-mesenchymal transition in cancer metastasis: new insight into the roles of transcription factors. Front Oncol. 2021;11:762817.","journal-title":"Front Oncol"},{"key":"3178_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113610","volume":"154","author":"S Nisar","year":"2022","unstructured":"Nisar S, et al. Natural products as chemo-radiation therapy sensitizers in cancers. Biomed Pharmacother. 2022;154:113610.","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"3178_CR37","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.3390\/cancers15153980","volume":"15","author":"N Choudhary","year":"2023","unstructured":"Choudhary N, et al. Targeting cell signaling pathways in lung cancer by bioactive phytocompounds. Cancers. 2023;15(15):3980.","journal-title":"Cancers"},{"key":"3178_CR38","volume":"5","author":"MS Islam","year":"2022","unstructured":"Islam MS, et al. The role of inflammations and EMT in carcinogenesis. Adv Cancer Biol. 2022;5:100055.","journal-title":"Adv Cancer Biol"},{"key":"3178_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1533352","volume":"15","author":"Y-T Ma","year":"2025","unstructured":"Ma Y-T, et al. Mechanisms of the JNK\/p38 MAPK signaling pathway in drug resistance in ovarian cancer. Front Oncol. 2025;15:1533352.","journal-title":"Front Oncol"},{"issue":"12","key":"3178_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/acscombsci.0c00099","volume":"22","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, et al. Progress in natural compounds\/siRNA co-delivery employing nanovehicles for cancer therapy. ACS Comb Sci. 2020;22(12):669\u2013700.","journal-title":"ACS Comb Sci"},{"key":"3178_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2025.156243","author":"RK Sahoo","year":"2025","unstructured":"Sahoo RK, et al. Integrative computational and experimental validation of Piperlongumine as a therapeutic agent targeting differentially expressed genes in colorectal cancer. Pathology. 2025. https:\/\/doi.org\/10.1016\/j.prp.2025.156243.","journal-title":"Pathology"},{"key":"3178_CR42","doi-asserted-by":"publisher","DOI":"10.1039\/D4NR01483A","author":"JA Santos","year":"2024","unstructured":"Santos JA, et al. Platinum-based chemotherapy: trends in organic nanodelivery systems. Nanoscale. 2024;16:14640\u201314686 https:\/\/doi.org\/10.1039\/D4NR01483A.","journal-title":"Nanoscale"},{"issue":"14","key":"3178_CR43","doi-asserted-by":"publisher","first-page":"8430","DOI":"10.1002\/jsfa.13612","volume":"104","author":"R Solanki","year":"2024","unstructured":"Solanki R, Patel S. Evodiamine and its nano-based approaches for enhanced cancer therapy: recent advances and challenges. J Sci Food Agric. 2024;104(14):8430\u201344.","journal-title":"J Sci Food Agric"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-03178-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-03178-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T03:50:18Z","timestamp":1769485818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-03178-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3178"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-03178-2","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declares no conflict of Interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"42"}}